Scarica l'app Stockscreener
2.16
4.42%
-0.10
Precedente Chiudi:
$2.26
Aprire:
$2.23
Volume 24 ore:
220.34K
Relative Volume:
0.16
Capitalizzazione di mercato:
$22.49M
Reddito:
-
Utile/perdita netta:
$-45.57M
Rapporto P/E:
-0.3429
EPS:
-6.3
Flusso di cassa netto:
$-38.56M
1 W Prestazione:
-16.28%
1M Prestazione:
-1.57%
6M Prestazione:
+35.00%
1 anno Prestazione:
-23.67%
Intervallo 1D:
$2.14
$2.35
Intervallo di 1 settimana:
$2.14
$2.9193
Portata 52W:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Nome
Sab Biotherapeutics Inc
Settore
Industria
Telefono
305-845-2813
Indirizzo
777 W 41ST ST, MIAMI BEACH
Confronta SABS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.16 | 23.53M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Leerink Partners | Outperform |
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-10-09 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-05 | Iniziato | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Borsa (SABS) Ultime notizie
Using data filters to optimize entry into SAB Biotherapeutics Inc.July 2025 Movers & Daily Stock Trend Reports - newser.com
Using R and stats models for SAB Biotherapeutics Inc. Equity Warrant forecasting2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Visual trend scoring systems applied to SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Can technical indicators confirm SAB Biotherapeutics Inc.’s reversalPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Will a bounce in SAB Biotherapeutics Inc. Equity Warrant offer an exitTrade Ideas & Daily Stock Momentum Reports - newser.com
Is SAB Biotherapeutics Inc. stock reversal real or fakeJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com
Full technical analysis of SAB Biotherapeutics Inc. stockEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Strategies to average down on SAB Biotherapeutics Inc. Equity Warrant2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Is SAB Biotherapeutics Inc. stock bottoming out2025 Price Momentum & Expert Approved Trade Ideas - newser.com
Will SAB Biotherapeutics Inc. see short term momentumJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Identifying reversal signals in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Institutional & Technical Confirmation Alerts - newser.com
SAB Biotherapeutics stock maintains Buy rating at H.C. Wainwright on positive diabetes treatment data - Investing.com
How to build a dashboard for SAB Biotherapeutics Inc. stock2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Forecasting SAB Biotherapeutics Inc. Equity Warrant price range with options dataCEO Change & Accurate Intraday Trade Tips - newser.com
Institutional scanner results for SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
SAB Biotherapeutics Inc. Equity Warrant stock prediction for this weekJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Chardan Capital Reaffirms Buy Rating for SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Is it time to cut losses on SAB Biotherapeutics Inc. Equity Warrant2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
S P Trends: Will SAB Biotherapeutics Inc outperform during market ralliesRate Cut & Stepwise Trade Signal Implementation - خودرو بانک
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Receives Average Rating of “Buy” from Analysts - Defense World
Will SAB Biotherapeutics Inc. bounce back from current supportBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
SABS News Today | Why did SAB Biotherapeutics stock drop today? - MarketBeat
SAB Biotherapeutics (NASDAQ:SABS) Upgraded at Wall Street Zen - Defense World
Q3 Earnings Estimate for SABS Issued By Leerink Partnrs - Defense World
Will SAB Biotherapeutics Inc. Equity Warrant stock go up soonJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Does SAB Biotherapeutics Inc. qualify in momentum factor screening2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Aug Outlook: Is SAB Biotherapeutics Inc stock a falling knife or bargain buyJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Aug Reactions: Is SAB Biotherapeutics Inc. Equity Warrant stock undervalued right nowJuly 2025 Levels & AI Powered Market Trend Analysis - خودرو بانک
what data driven models say about sab biotherapeutics inc.’s futureQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Is SAB Biotherapeutics Inc. stock poised for growthQuarterly Market Summary & Daily Price Action Insights - newser.com
Intraday pattern recognizer results for SAB Biotherapeutics Inc.Portfolio Growth Summary & Community Verified Trade Alerts - newser.com
Chart based exit strategy for SAB Biotherapeutics Inc. Equity WarrantMarket Movers & Verified Technical Signals - newser.com
Stock Report: Should you buy the dip on Allakos IncJuly 2025 Momentum & Fast Gain Swing Trade Alerts - khodrobank.com
Signal Recap: What’s next for SAB Biotherapeutics Inc. stock2025 Geopolitical Influence & Weekly High Return Stock Opportunities - خودرو بانک
What institutional flow reveals about SAB Biotherapeutics Inc.July 2025 WrapUp & Verified Chart Pattern Signals - newser.com
Whats the beta of Vision Marine Technologies Inc stock2025 Technical Overview & Precise Swing Trade Alerts - khodrobank.com
SAB BIO Highlights Data in Multiple Presentations at EASD - GlobeNewswire
Breakthrough in Type 1 Diabetes: SAB BIO's SAB-142 Shows Sustained Effects Without Lymphodepletion in Phase 1 - Stock Titan
Published on: 2025-09-19 14:28:48 - خودرو بانک
Risk Off: Can CVRx Inc weather a recessionWeekly Trade Review & Daily Volume Surge Signals - khodrobank.com
Aug Swings: What is SAB Biotherapeutics Inc. Equity Warrant’s TAM (Total Addressable Market)July 2025 Review & Weekly Momentum Picks - خودرو بانک
SAB Biotherapeutics Inc. Equity Warrant stock trendline breakdownPortfolio Growth Summary & High Accuracy Trade Alerts - newser.com
What moving averages say about SAB Biotherapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-09-19 05:54:36 - خودرو بانک
institutional scanner results for sab biotherapeutics inc. equity warrantPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Regression analysis insights on SAB Biotherapeutics Inc. Equity Warrant performanceMarket Performance Report & High Accuracy Investment Signals - newser.com
Top Moving Stock Now – SAB Biotherapeutics Inc (NASDAQ: SABS) - stocksregister.com
Will breakout in SAB Biotherapeutics Inc. Equity Warrant lead to full recoveryOil Prices & Free Technical Pattern Based Buy Signals - newser.com
SAB Biotherapeutics Presents Phase I Data on SAB-142 Showing Transient Lymphocyte Declines in Healthy Volunteers at 2025 EASD Conference - geneonline.com
Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):